When making regulatory decisions about a drug, the U.S. Food and Drug Administration (FDA) often relies on advisory committees to provide independent advice. (U.S ...

A panel of advisers to the U.S. health regulator on Tuesday voted against a therapy based on the party drug MDMA for patients with post-traumatic stress disorder, in a major setback to the nascent ...